Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Dru logo Bentham Science Publishers logo

This journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Topics related to the neuroendocrine-immune axis are given special emphasis in view of the growing interest in stress-related, inflammatory, autoimmune, and degenerative disorders.

Publisher: Bentham Science Publishers

Volume 6, Number 4, December 2006
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Articles

Editorial [Hot Topic: Recent Developments and Future Directions in the Treatment of Systemic Rheumatic Diseases (Guest Editor: Minoru Satoh) ]
pp. 303-304(2)
Author: Satoh, Minoru

Signaling Abnormalities in Systemic Lupus Erythematosus as Potential Drug Targets
pp. 305-311(7)
Authors: Fernandez, David; Bonilla, Eduardo; Phillips, Paul; Perl, Andras

Blockade of Chemokine-Mediated Tissue Injury in Lupus Nephritis
pp. 313-321(9)
Authors: Vielhauer, Volker; Anders, Hans-Joachim

Type I Interferon as a Target of Treatment in SLE
pp. 323-330(8)
Authors: Lee, P. Y.; Reeves, W. H.

Viral Anti-Inflammatory Reagents: The Potential for Treatment of Arthritic and Vasculitic Disorders
pp. 331-343(13)
Authors: Munuswamy-Ramanujam, G.; Khan, K. A.; Lucas, A. R.

Targeting B Cells in SLE: The Experience with Rituximab Treatment (Anti-CD20)
pp. 345-350(6)
Author: Eisenberg, Robert

Therapeutic Targeting of B Lymphocyte Stimulator (BLyS) in the Rheumatic Diseases
pp. 351-358(8)
Author: Stohl, William

NF-κ B and Rheumatic Diseases
pp. 359-372(14)
Author: Okamoto, Takashi

Anti-Interleukin-6 Receptor Antibody Therapy in Rheumatic Diseases
pp. 373-381(9)
Authors: Nakahara, Hideko; Nishimoto, Norihiro

Role of PGE2 and EP Receptors in the Pathogenesis of Rheumatoid Arthritis and as a Novel Therapeutic Strategy
pp. 383-394(12)
Authors: Akaogi, Jun; Nozaki, Toshiko; Satoh, Minoru; Yamada, Hidehiro

Targeting Fibrosis in Systemic Sclerosis
pp. 395-400(6)
Author: Lafyatis, Robert

Targeting Vascular Disease in Systemic Sclerosis
pp. 401-407(7)
Author: Kowal-Bielecka, Otylia

Recent Advances in the Treatment of Interstitial Lung Disease in Patients with Polymyositis/Dermatomyositis
pp. 409-415(7)
Authors: Kameda, Hideto; Takeuchi, Tsutomu

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A